TalkMed Group Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for TalkMed Group.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth18.8%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

TalkMed Group (SGX:5G3) Seems To Use Debt Quite Sensibly

Sep 26
TalkMed Group (SGX:5G3) Seems To Use Debt Quite Sensibly

Unpleasant Surprises Could Be In Store For TalkMed Group Limited's (SGX:5G3) Shares

Apr 08
Unpleasant Surprises Could Be In Store For TalkMed Group Limited's (SGX:5G3) Shares

TalkMed Group's (SGX:5G3) Solid Earnings Have Been Accounted For Conservatively

Mar 01
TalkMed Group's (SGX:5G3) Solid Earnings Have Been Accounted For Conservatively

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as TalkMed Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SGX:5G3 - Analysts future estimates and past financials data (SGD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202479283434N/A
3/31/202481303738N/A
12/31/202384324142N/A
9/30/202383314243N/A
6/30/202382314445N/A
3/31/202379314041N/A
12/31/202277313737N/A
9/30/202270283232N/A
6/30/202264262626N/A
3/31/202263262425N/A
12/31/202161252223N/A
9/30/202162252123N/A
6/30/202160232224N/A
3/31/202161232628N/A
12/31/202062232931N/A
9/30/202067273233N/A
6/30/202071313637N/A
3/31/202074343434N/A
12/31/201976363436N/A
9/30/201973343237N/A
6/30/201971332834N/A
3/31/201966312833N/A
12/31/201861292630N/A
9/30/201858282727N/A
6/30/201855272727N/A
3/31/20185729N/A30N/A
12/31/20176132N/A31N/A
9/30/20176534N/A38N/A
6/30/20176835N/A41N/A
3/31/20176937N/A40N/A
12/31/20166937N/A45N/A
9/30/20166837N/A42N/A
6/30/20166736N/A40N/A
3/31/20166636N/A40N/A
12/31/20156637N/A40N/A
9/30/20156538N/A40N/A
6/30/20156540N/A41N/A
3/31/20156540N/A40N/A
12/31/20146339N/A28N/A
9/30/20146132N/A39N/A
6/30/20145931N/A29N/A
3/31/20145830N/A27N/A
12/31/20135628N/A36N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 5G3's forecast earnings growth is above the savings rate (2.2%).

Earnings vs Market: Insufficient data to determine if 5G3's earnings are forecast to grow faster than the SG market

High Growth Earnings: Insufficient data to determine if 5G3's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 5G3's revenue is forecast to grow faster than the SG market.

High Growth Revenue: Insufficient data to determine if 5G3's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 5G3's Return on Equity is forecast to be high in 3 years time


Discover growth companies